首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
【24h】

Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse

机译:在小鼠口服和直肠给药后,表面化学对纳米颗粒与胃肠粘液的相互作用以及在胃肠道中的分布的影响

获取原文
获取原文并翻译 | 示例
           

摘要

It is believed that mucoadhesive surface properties on particles delivered to the gastrointestinal (GI) tract improve oral absorption or local targeting of various difficult-to-deliver drug classes. To test the effect of nanoparticle mucoadhesion on distribution of nanoparticles in the GI tract, we orally and rectally administered nano-and microparticles that we confirmed possessed surfaces that were either strongly mucoadhesive or non-mucoadhesive. We found that mucoadhesive particles (MAP) aggregated in mucus in the center of the GI lumen, far away from the absorptive epithelium, both in healthy mice and in a mouse model of ulcerative colitis (UC). In striking contrast, water absorption by the GI tract rapidly and uniformly transported non-mucoadhesive mucus-penetrating particles (MPP) to epithelial surfaces, including reaching the surfaces between villi in the small intestine. When using high gavage fluid volumes or injection into ligated intestinal loops, common methods for assessing oral drug and nanoparticle absorption, we found that both MAP and MPP became well-distributed throughout the intestine, indicating that the barrier properties of GI mucus were compromised. In the mouse colorectum, MPP penetrated into mucus in the deeply in-folded surfaces to evenly coat the entire epithelial surface. Moreover, in a mouse model of UC, MPP were transported preferentially into the disrupted, ulcerated tissue. Our results suggest that delivering drugs in non-mucoadhesive MPP is likely to provide enhanced particle distribution, and thus drug delivery, in the GI tract, including to ulcerated tissues. (C) 2014 Elsevier B.V. All rights reserved.
机译:相信递送到胃肠(GI)道的颗粒上的粘膜粘附表面性质改善了各种难以递送的药物类别的口服吸收或局部靶向。为了测试纳米颗粒粘膜粘附对胃肠道中纳米颗粒分布的影响,我们口服和直肠施用了纳米颗粒和微粒,我们确认其具有强粘膜粘附性或非粘膜粘附性的表面。我们发现在健康小鼠和溃疡性结肠炎(UC)小鼠模型中,粘膜粘附颗粒(MAP)聚集在胃肠道腔中央的粘液中,远离吸收性上皮。与之形成鲜明对比的是,胃肠道的吸水迅速且均匀地将非粘膜粘附性粘液穿透颗粒(MPP)转运到上皮表面,包括到达小肠绒毛之间的表面。当使用高管量的液体或注射入结扎的肠loop(用于评估口服药物和纳米颗粒吸收的常用方法)时,我们发现MAP和MPP均在整个肠内分布良好,表明GI粘液的屏障特性受到损害。在小鼠结肠直肠中,MPP渗透到深度向内折叠的表面的粘液中,均匀地覆盖了整个上皮表面。此外,在UC小鼠模型中,MPP优先运输到破裂的溃疡组织中。我们的研究结果表明,在非粘膜粘附性MPP中递送药物可能会增强胃肠道中的颗粒分布,从而促进药物在胃肠道中的递送,包括溃疡组织。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号